South Korea’s rapid investment in digital health and telemedicine services is creating a unique opportunity and necessity for the integration of remote diagnostic solutions, significantly impacting the immunoassay sector. As virtual consultations and remote patient monitoring become increasingly common, there is a substantial demand for diagnostic devices that can deliver quick, reliable...